Key facts
- This page summarizes George Cappy's Form 4 filing for MIRA PHARMACEUTICALS, INC. (MIRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 24 Aug 2023, 17:38.
George Cappy - 07 Aug 2023 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- MIRA
- Reported as of
- 07 Aug 2023
- Net transaction value
- +$833,336
- SEC form
- 4
- Accepted by SEC
- 24 Aug 2023, 17:38:43 UTC
- Prior SEC filing
- 04 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michelle Yanez, Attorney-in-Fact for George Cappy
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
George Cappy filed Form 4 for MIRA PHARMACEUTICALS, INC. (MIRA) on 24 Aug 2023.
Change
- Previous filing in this sequence was filed on 04 Aug 2023.
- Current net transaction value: +$833,336.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MIRA
transaction
Common Stock
Purchase
- Transaction value
- $833,336
- Shares
- +119,048
- Change %
- +4.3%
- Price
- $7.00
- Shares after
- 2,859,318
- Date
- 07 Aug 2023
- Ownership
- By Trust
- Footnotes
- F1
MIRA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 20,000
- Date
- 07 Aug 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These securities are owned directly by the Bay Shore Trust (the "Trust"), a greater-than-10% owner of the Issuer. As sole trustee of the Trust, George Cappy ("Mr. Cappy") has sole ownership and dispositive power over these securities and is therefore deemed to be an indirect beneficial owner of the securities for purposes of SEC Rule 13d-3, although Mr. Cappy disclaims beneficial ownership of the reported securities due to the absence of any pecuniary interest therein.
Footnote F2
These securities are owned directly by Mr. Cappy.